Clinical Trial Update: HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study evaluating two antibodies, TMB-365 and TMB-380, for achieving HIV-1 virologic suppression. The trial is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TMB-365
• TMB-380

Snippet

Sponsor: TaiMed Biologics Inc. | Conditions: HIV -1 Infection | Phase 2 | Status: RECRUITING